Positive topline Phase 2a biomarker data position VTX3232 as a potential disease-modifying therapy for patients with Parkinson’s diseaseData from the Phase 2 study of VTX2735 in patients with ...

Western PhD student Olusoji Ogunbode spent the summer in Nigeria testing wearable technology to track Parkinson’s symptoms in real time.